Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (DRKS00041177) titled 'EVITA - EndoVascular Intervention and Targeted Glucose Adjustment: A prospective randomized feasibility study investigating two target ranges of intravenous glucose control after successful endovascular therapy for acute ischemic stroke' on July 30.
Study Type: interventional
Study Design:
Allocation: Randomized controlled study
Masking: Open (masking not used)
Control: active
Assignment: parallel
Study design purpose: treatment
Primary Sponsor: Universitatsklinikum Heidelberg, Neurologische Klinik
Condition:
Acute ischemic stroke after successful endovascular therapy in patients with known diabetes mellitus or a...